scispace - formally typeset
E

Emad S. Alnemri

Researcher at Thomas Jefferson University

Publications -  228
Citations -  75133

Emad S. Alnemri is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Apoptosis & Caspase. The author has an hindex of 106, co-authored 223 publications receiving 67441 citations. Previous affiliations of Emad S. Alnemri include QIMR Berghofer Medical Research Institute & Laval University.

Papers
More filters
Journal ArticleDOI

Mechanism of XIAP-Mediated Inhibition of Caspase-9

TL;DR: It is demonstrated that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization, which defines a unified mechanism for the activation of all caspases.
Journal ArticleDOI

The AIM2 inflammasome is critical for innate immunity to Francisella tularensis

TL;DR: This study identifies AIM2 as a crucial sensor of F. tularensis infection and provides genetic proof of its critical role in host innate immunity to intracellular pathogens.
Journal ArticleDOI

Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL

TL;DR: TRAIL receptor-3 may function as an antagonistic decoy receptor to attenuate the cytotoxic effect of TRAIL in most tissues that are TRAIL+, DR4+, and DR5+.
Journal ArticleDOI

Structural Basis of Caspase-7 Inhibition by XIAP

TL;DR: The biochemical and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7, and provides a structural basis for the design of the next-generation caspases.
Journal ArticleDOI

Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation

TL;DR: In mouse macrophages, signaling by the pattern recognition receptor TLR4 through MyD88 can rapidly and non-transcriptionally prime NLRP3 by stimulating its deubiquitination, which could explain how NL RP3 is activated by diverse danger signals.